Short and long term treatment of essential hypertension with felodipine as monotherapy. 1987

K Harrington, and P Fitzgerald, and P O'Donnell, and K W Hill, and E O'Brien, and K O'Malley

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009568 Nitrendipine A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive. Balminil,Bay e 5009,Bayotensin,Baypresol,Baypress,Gericin,Jutapress,Nidrel,Niprina,Nitre AbZ,Nitre-Puren,Nitregamma,Nitren 1A Pharma,Nitren Lich,Nitren acis,Nitrend KSK,Nitrendepat,Nitrendi Biochemie,Nitrendidoc,Nitrendimerck,Nitrendipin AL,Nitrendipin Apogepha,Nitrendipin Atid,Nitrendipin Basics,Nitrendipin Heumann,Nitrendipin Jenapharm,Nitrendipin Lindo,Nitrendipin Stada,Nitrendipin beta,Nitrendipin-ratiopharm,Nitrendipino Bayvit,Nitrendipino Ratiopharm,Nitrensal,Nitrepress,Tensogradal,Trendinol,Vastensium,nitrendipin von ct,nitrendipin-corax,Nitre Puren,NitrePuren,Nitrendipin ratiopharm,Nitrendipinratiopharm,nitrendipin corax,nitrendipincorax
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

K Harrington, and P Fitzgerald, and P O'Donnell, and K W Hill, and E O'Brien, and K O'Malley
September 1997, The American journal of cardiology,
K Harrington, and P Fitzgerald, and P O'Donnell, and K W Hill, and E O'Brien, and K O'Malley
January 1990, Journal of cardiovascular pharmacology,
K Harrington, and P Fitzgerald, and P O'Donnell, and K W Hill, and E O'Brien, and K O'Malley
March 1988, Journal of hypertension,
K Harrington, and P Fitzgerald, and P O'Donnell, and K W Hill, and E O'Brien, and K O'Malley
March 1993, Blood pressure,
K Harrington, and P Fitzgerald, and P O'Donnell, and K W Hill, and E O'Brien, and K O'Malley
January 1987, Drugs,
K Harrington, and P Fitzgerald, and P O'Donnell, and K W Hill, and E O'Brien, and K O'Malley
January 1993, Nephron,
K Harrington, and P Fitzgerald, and P O'Donnell, and K W Hill, and E O'Brien, and K O'Malley
April 1990, Journal of cardiovascular pharmacology,
K Harrington, and P Fitzgerald, and P O'Donnell, and K W Hill, and E O'Brien, and K O'Malley
January 1990, European journal of clinical pharmacology,
K Harrington, and P Fitzgerald, and P O'Donnell, and K W Hill, and E O'Brien, and K O'Malley
December 1981, Clinical pharmacology and therapeutics,
K Harrington, and P Fitzgerald, and P O'Donnell, and K W Hill, and E O'Brien, and K O'Malley
January 1990, Annals of the Academy of Medicine, Singapore,
Copied contents to your clipboard!